Research
Login or register to access the content restricted to healthcare professionals only
Bod MediCabilis™ Phase I clinical study
Bod Australia has invested in phase 1 clinical study that assessed the safety, tolerability and pharmacokinetics of the Bod MediCabilis™ 5% CBD Cannabis sativa, full-spectrum extract in oil.
The research was conducted at Nucleus Network and published in the prestigious British Journal of Clinical Pharmacology.
